Results 11 to 20 of about 22,249,811 (294)

Anti-PD-1 antibody decreases tumour-infiltrating regulatory T cells [PDF]

open access: yesBMC Cancer, 2020
Background There are many types of therapies for cancer. In these days, immunotherapies, especially immune checkpoint inhibitors, are focused on. Though many types of immune checkpoint inhibitors are there, the difference of effect and its mechanism are ...
Kazushige Yoshida   +15 more
doaj   +2 more sources

Association of PD-1 gene polymorphisms and serum soluble PD-1 levels with type 1 diabetes mellitus susceptibility in a Chinese Han cohort: a case-control study [PDF]

open access: yesFrontiers in Immunology
BackgroundThe programmed cell death 1 (PD-1)/PD-L1 pathway plays a critical role in immune tolerance and has been implicated in type 1 diabetes mellitus (T1DM).
Renhao Zhao   +6 more
doaj   +2 more sources

Molecular dynamics insights into the redox effects on PD-1/PD-L1 and PD-1/PD-L2 interactions [PDF]

open access: yesScientific Reports
The PD-1/PD-L1/PD-L2 immune checkpoint plays a critical role in regulating immune responses, and its dysfunction is implicated in immune evasion by cancer cells.
Rasulbek Mashalov   +3 more
doaj   +2 more sources

The clinical importance of PD‑L1 and PD‑1 expression in diffuse large B cell lymphoma [PDF]

open access: yesArchives of the Balkan Medical Union, 2018
Introduction. The target pathway programmed cell death‑1 (PD‑1)/ programmed death‑ligand 1 (PD‑L1) shows clinical efficacy in solid tumors, but also in Hodgkin’s and non‑Hodgkin’s lymphoma. PD‑L1 expression most often correlates with a poor prognosis and
Adelina BIRCEANU COROBEA   +7 more
doaj   +2 more sources

The PD‐1 Interactome [PDF]

open access: yesAdvanced Biology, 2021
AbstractT cell activation is a fine‐tuned process that involves T cell receptor and costimulation signals. To prevent undue activation of T cells, inhibitory molecules including PD‐1 (programmed death 1) are induced and function as brakes for T cell signaling.
Qi Wang   +3 more
openaire   +2 more sources

نقش PD-1/ PD-L1 و Anti-PD-1/ PD-L1 در پیشرفت و سرکوب سرطان [PDF]

open access: yesMajallah-i Dānishkadah-i Pizishkī-i Dānishgāh-i ̒ Ulūm-i Pizishkī-i Mashhad., 2023
نقاط کنترل ایمنی (Immune checkpoints) مجموعه ای از گیرنده های تنظیمی می باشند که باعث کنترل پاسخ های ایمنی، حفظ تولرانس و هموستاز می شود. سلول های توموری می توانند با به خدمت گرفتن این نقاط از دسترس پاسخ های اختصاصی ضد تومورال بگریزند و گسترش پیدا کنند ...
نرگس عبدالهی   +3 more
doaj   +1 more source

Towards European Transitions: Indicators for the Development of Marginal Urban Regions

open access: yesLand, 2022
Urban transitions and urban-scape have been heavily impacted by the COVID-19 pandemic and will likely be affected by the current Ukrainian-Russian conflict.
Rubina Canesi, Giuliano Marella
doaj   +1 more source

Research at the University of Padova in the Field of Space Debris Impacts against Satellites: An Overview of Activities in the Last 10 Years

open access: yesApplied Sciences, 2023
Space debris represent a threat to satellites in orbit around Earth. In the case of impact, satellites can be subjected to damage spanning from localized craterization to subsystem failure, to complete loss of the vehicle; large collision events may lead
Lorenzo Olivieri   +3 more
doaj   +1 more source

Recognition of Additive Manufacturing Parts Based on Neural Networks and Synthetic Training Data: A Generalized End-to-End Workflow

open access: yesApplied Sciences, 2023
Additive manufacturing (AM) is becoming increasingly relevant among established manufacturing processes. AM parts must often be recognized to sort them for part- or order-specific post-processing.
Jonas Conrad   +4 more
doaj   +1 more source

Effect of platelet rich plasma in non surgically treated chronic Achilles tendon ruptures

open access: yesFoot & Ankle Surgery: Techniques, Reports & Cases, 2023
Background: Achille's tendon ruptures are relatively common among foot and ankle injuries. They are considered chronic when last beyond 4-6 weeks from the time of injuries.
Paolo Lorenzon, MD   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy